CHANGES IN THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER THE USE OF BIOREGULATORY DRUGS

Authors

  • Xamraev Farid Xamidullaevich
  • Ismailov Jamshid Abduraimovich
  • Rasuli Farida Orifovna
  • Xamidullaev Firdavs Faridovich
  • Kamalov Anvar Ibragimovich

Keywords:

chronic obstructive pulmonary disease, inflammation, quality of life, bioregulatory drugs.

Abstract

The quality of life (QOL) of patients with chronic obstructive pulmonary disease is currently one of the main indicators for assessing the effectiveness of therapy. This indicator is directly related to health, is one of the key concepts of modern medicine and allows us to carry out an in-depth analysis of important components of human health in accordance with WHO criteria. All patients (168 patients with COPD, 90 of whom had ischaemic heart disease) were divided into 2 groups: the main group (60 patients) received baseline therapy and bioregulatory drugs, and the control group (108 patients) received only baseline therapy. QOL was assessed using the SF-36 questionnaire.

References

Dusanovich D. A. et al. NONSPESIFIK YARALI KOLITNING KLINIK VA IMMUNOLOGIK XUSUSIYATLARI //JOURNAL OF BIOMEDICINE AND PRACTICE. – 2022. – Т. 7. – №. 5.

Fazilova G. et al. The role of certain regulatory cytokines in the immunopathogenesis of extrinsic allergic alveolitis. – 2018.

Kholliyev R. et al. The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course. – 2015.

Rubenovna A. I. et al. Assessment Of The Degree Of Endothelial Dysfunction In Patients With Chronic Obstructive Pulmonary Disease Complicated By Chronic Heart Failure //Int. J. of Aquatic Science. – 2021. – Т. 12. – №. 3. – С. 2917-2922.

Rubenovna A. I. et al. Assessment Of The Degree Of Endothelial Dysfunction In Patients With Chronic Obstructive Pulmonary Disease Complicated By Chronic Heart Failure //Int. J. of Aquatic Science. – 2021. – Т. 12. – №. 3. – С. 2917-2922.

Rubenovna A. I. et al. DIAGNOSTIC VALUE OF IL-8 AND IL-12 IN VARIOUS FORMS OF INTERSTITIAL LUNG DISEASE //Asian journal of pharmaceutical and biological research. – 2022. – Т. 11. – №. 2.

Yusufovna K. N. et al. Pharmacogenetics-A New Word in the Treatment of Rheumatoid Arthritis //Annals of the Romanian Society for Cell Biology. – 2021. – С. 259-265.

Ziyadullaev S. et al. The effect of budesonide on the quality of life in patients with bronchial asthma //European Journal of Molecular & Clinical Medicine. – 2020. – Т. 7. – №. 2. – С. 1760-1766.

Ziyadullaev S. et al. The effect of budesonide on the quality of life in patients with bronchial asthma //European Journal of Molecular & Clinical Medicine. – 2020. – Т. 7. – №. 2. – С. 1760-1766.

Зиядуллаев Ш. Х. и др. Роль некоторых регуляторных цитокинов в иммунопатогенезе экзогенных аллергических альвеолитов //Здобутки клінічної i експериментальної медицини. – 2017. – №. 1. – С. 38-41.

Холжигитова М. Б. и др. Клиническая и бронхоскопическая характеристика воспалительного процесса у больных хроническим обструктивным бронхитом //Вопросы науки и образования. – 2019. – №. 25 (74). – С. 55-63.

Холжигитова М. Б., Аралов Н. Р., Дусанов А. Д. Уровень факторов местного иммунитета при хроническом обструктивном бронхите у лиц подросткового возраста //Тюменский медицинский журнал. – 2016. – Т. 18. – №. 1. – С. 52-55.

Downloads

Published

2024-02-01